Have a personal or library account? Click to login
Determination of donepezil hydrochloride in human plasma and pharmaceutical formulations by HPLC with fluorescence detection Cover

Determination of donepezil hydrochloride in human plasma and pharmaceutical formulations by HPLC with fluorescence detection

Open Access
|Dec 2011

References

  1. H. Sugimoto, Y. Tsuchiya, H. Sungmi, K. Higurahi, N. Karibe, Y. Iimur, A. Sasaki, Y. Kawakami, T. Nakamura, S. Araki, Y. Yamanishi and K. Yamatssu, Novel piperidine derivatives. Synthesis and anti-acetylcholinesterase activity of 1-benzyl-4-[2-(N-benzoylamino)ethyl]piperidine derivatives, J. Med. Chem. 33 (1990) 1880-1887.10.1021/jm00169a008
  2. I. T. Lott, K. Osann, E. Dorn and L. Nelson, Down syndrome and Alzheimer disease: response to donepezil, Arch. Neurol. 59 (2002) 1133-1136.10.1001/archneur.59.7.1133
  3. S. Kafkala, S. Matthaiou, P. Alexaki, M. Abatzis, A. Bartzeliotis and M. Katsiabani, New gradient high-performance liquid chromatography method for determination of donepezil hydrochloride assay and impurities content in oral pharmaceutical formulation, J. Chromatogr. A 1189 (2008) 392-397; DOI: 10.1016/j.chroma.2007.12.015.10.1016/j.chroma.2007.12.015
  4. H. Pappa, R. Farrú, P. O. Vilanova, M. Palacios and M. T. Pizzorno, A new HPLC method to determine donepezil hydrochloride in tablets, J. Pharm. Biomed. Anal. 27 (2002) 177-182.10.1016/S0731-7085(01)00499-X
  5. B. S. Sultry, S. Gananadhamu, D. Devadasu and K. Balaji, New RP-HPLC method for estimation of donepezil hydrochloride in pharmaceutical formulations, Int. J. Chem. Sci. 6 (2008) 1976-1983.
  6. N. Y. Furukori, R. Furuya, T. Takahata and T. Tateishi, Determination of donepezil, an acetylcholinesterase inhibitor, in human plasma by high-performance liquid chromatography with ultraviolet absorbance detection, J. Chromatogr. B 768 (2002) 261-265.10.1016/S1570-0232(01)00592-X
  7. M. A. Radwan, H. H. Abdine, B. T. Al-Quadeb, H. Y. Aboul-Enien and K. Nakashima, Stereoselective HPLC assay of donepezil enantiomers with UV detection and its application to pharmacokinetic in rats, J. Chromatogr. B. 830 (2006) 114-119; DOI: 10.1016/j.jchromb.2005.10.031.10.1016/j.jchromb.2005.10.031
  8. J. S. Hiten, L. K. Mohan, P. Ankit, P. Shivkumar, S. Gunta, P. N. Chhagan, M. P. Dasharath and N. S. Bhanu, A rapid and specific approach for direct measurement of donepezil concentration in human plasma by LC-MS/MS employing solid-phase extraction, Biomed. Chromatogr. 23 (2009) 141-151, DOI: 10.1002/bmc.1095.10.1002/bmc.1095
  9. P. E. Jeong, L. H. Won, J. H. Young, K. H. Yoon, L. M. Hyung, P. Eun-Seok, L. K. Choon and L. H. Suk, Hydrophilic interaction chromatography-tandem mass spectrometry of donepezil in human plasma: Application to a pharmacokinetic study of donepezil in volunteers, Arch. Pharm. Res. 31(2008) 1205-1211.
  10. Y. Hsin-Hua, Y. Yuan-Han, K. Ju-Yun and C. Su-Hwei, Sensitive analysis of donepezil in plasma by capillary electrophoresis combining on-column field-amplified sample stacking and its application of Alzheimer's disease, Electrophoresis 29 (2008) 3649-3657; DOI: 10.1002/elps.200800276.10.1002/elps.200800276
  11. K. Nakashima, K. Itoh, M. Kono, M. N. Nakashima and M. Wada, Determination of donepezil hydrochloride in human and rat plasma, blood and brain microdialysates by HPLC with a short C30 column, J. Pharm. Biomed. Anal. 41 (2006) 201-206; DOI: 10.1016/j.jpba.2005.10.017.10.1016/j.jpba.2005.10.017
  12. G. M. Khaledi, Micelles as separation media in high-performance liquid chromatography and high-performance capillary electrophoresis: overview and perspective, J. Chromatog. A 780 (1997) 3-40.10.1016/S0021-9673(97)00610-9
  13. V. Meyer, Practical High-Performance Liquid Chromatography, 3rd ed., Royal Society of Chemistry, London, 1998, pp. 14-16.
  14. FDA Guidance for Industry: Bioanaytical Method Validation, US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER), Rockville (MD) 2001.
  15. G. A. Shabir, Validation of high-performance liquid chromatography methods for pharmaceutical analysis, understanding the differences and similarities between validation requirements of the US Food and Drug Administration, the US Pharmacopeia and the International Conference on Harmonization, J. Chromatogr. A 987 (2003) 57-59; DOI: 10.1016/S0021-9673(02)01536-4.10.1016/S0021-9673(02)01536-4
  16. International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use, ICH Harmonised Tripartite Guideline, Validation of Analytical Procedures: Text and Methodology Q2(R1), Complementary Guideline on Methododology dated 06 November 1996, incorporated in November 2005, London.
  17. H. Ermer, Validation in pharmaceutical analysis. Part I. An integrated approach, J. Pharm. Biomed. Anal. 24 (2001) 755-767; DOI: 10.1016/S073-7085(00)00530-6.
  18. J. N. Miller and J. C. Miller, Statistics and Chemometrics for Analytical Chemistry, 5th ed., Tottenham (UK), 2005.
  19. Donepezil hydrochloride tablets, USP Pending Monograph Guideline, Version 2, USP Convention, Rockville (MD) 2009, USA http://www.usp.org
DOI: https://doi.org/10.2478/V10007-011-0035-1 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Language: English
Page range: 403 - 413
Published on: Dec 25, 2011
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:

© 2011 Mohammed Abonassif, Mohammed Hefnawy, Mohamed Kassem, Gamal Mostafa, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons License.

Volume 61 (2011): Issue 4 (December 2011)